1. Home
  2. RLMD vs BNRG Comparison

RLMD vs BNRG Comparison

Compare RLMD & BNRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RLMD
  • BNRG
  • Stock Information
  • Founded
  • RLMD 2004
  • BNRG 2012
  • Country
  • RLMD United States
  • BNRG Israel
  • Employees
  • RLMD N/A
  • BNRG N/A
  • Industry
  • RLMD Biotechnology: Pharmaceutical Preparations
  • BNRG
  • Sector
  • RLMD Health Care
  • BNRG
  • Exchange
  • RLMD Nasdaq
  • BNRG Nasdaq
  • Market Cap
  • RLMD 11.5M
  • BNRG 10.0M
  • IPO Year
  • RLMD N/A
  • BNRG 2022
  • Fundamental
  • Price
  • RLMD $0.40
  • BNRG $0.55
  • Analyst Decision
  • RLMD Hold
  • BNRG
  • Analyst Count
  • RLMD 4
  • BNRG 0
  • Target Price
  • RLMD $4.25
  • BNRG N/A
  • AVG Volume (30 Days)
  • RLMD 4.5M
  • BNRG 384.2K
  • Earning Date
  • RLMD 05-12-2025
  • BNRG 03-04-2025
  • Dividend Yield
  • RLMD N/A
  • BNRG N/A
  • EPS Growth
  • RLMD N/A
  • BNRG N/A
  • EPS
  • RLMD N/A
  • BNRG N/A
  • Revenue
  • RLMD N/A
  • BNRG N/A
  • Revenue This Year
  • RLMD N/A
  • BNRG N/A
  • Revenue Next Year
  • RLMD N/A
  • BNRG N/A
  • P/E Ratio
  • RLMD N/A
  • BNRG N/A
  • Revenue Growth
  • RLMD N/A
  • BNRG N/A
  • 52 Week Low
  • RLMD $0.24
  • BNRG $0.60
  • 52 Week High
  • RLMD $4.47
  • BNRG $3.27
  • Technical
  • Relative Strength Index (RSI)
  • RLMD 51.73
  • BNRG 21.99
  • Support Level
  • RLMD $0.36
  • BNRG $0.52
  • Resistance Level
  • RLMD $0.44
  • BNRG $1.09
  • Average True Range (ATR)
  • RLMD 0.08
  • BNRG 0.11
  • MACD
  • RLMD -0.00
  • BNRG -0.06
  • Stochastic Oscillator
  • RLMD 26.98
  • BNRG 3.37

About RLMD Relmada Therapeutics Inc.

Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its lead product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.

About BNRG Brenmiller Energy Ltd

Brenmiller Energy Ltd is a technology company that develops, produces, markets, and sells thermal energy storage. The technology of the company allows electrification and decarbonization of the industrial industry sector for integration with renewable energy sources and further reduction of carbon emissions.

Share on Social Networks: